10x Genomics, Inc.
TXG
$18.81
$0.060.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -13.83% | 11.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.83% | 11.64% | |||
| Cost of Revenue | 2.68% | -4.07% | |||
| Gross Profit | -20.06% | 19.00% | |||
| SG&A Expenses | 2.67% | -18.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.74% | -12.76% | |||
| Operating Income | -592.77% | 90.62% | |||
| Income Before Tax | -176.24% | 210.42% | |||
| Income Tax Expenses | -129.81% | 188.62% | |||
| Earnings from Continuing Operations | -179.54% | 200.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -179.54% | 200.52% | |||
| EBIT | -592.77% | 90.62% | |||
| EBITDA | -751.29% | 108.05% | |||
| EPS Basic | -178.43% | 199.61% | |||
| Normalized Basic EPS | -1,223.93% | 105.37% | |||
| EPS Diluted | -178.43% | 199.61% | |||
| Normalized Diluted EPS | -1,233.62% | 105.33% | |||
| Average Basic Shares Outstanding | 1.41% | 0.94% | |||
| Average Diluted Shares Outstanding | 0.80% | 1.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||